King Luther Capital Management Corp Takes $2.36 Million Position in Phreesia, Inc. $PHR

King Luther Capital Management Corp acquired a new position in shares of Phreesia, Inc. (NYSE:PHR) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 82,896 shares of the company’s stock, valued at approximately $2,359,000. King Luther Capital Management Corp owned approximately 0.14% of Phreesia as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in PHR. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Phreesia by 108.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,644,988 shares of the company’s stock worth $67,606,000 after acquiring an additional 1,377,904 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Phreesia by 3,741.9% during the 1st quarter. American Century Companies Inc. now owns 983,440 shares of the company’s stock worth $25,137,000 after purchasing an additional 957,842 shares during the last quarter. Nuveen LLC acquired a new position in shares of Phreesia during the first quarter worth $14,206,000. Champlain Investment Partners LLC increased its holdings in Phreesia by 20.0% in the first quarter. Champlain Investment Partners LLC now owns 2,946,489 shares of the company’s stock valued at $75,312,000 after buying an additional 490,340 shares during the last quarter. Finally, Park West Asset Management LLC increased its holdings in Phreesia by 111.2% in the first quarter. Park West Asset Management LLC now owns 894,501 shares of the company’s stock valued at $22,863,000 after buying an additional 470,931 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Insider Buying and Selling at Phreesia

In other Phreesia news, insider Evan Roberts sold 45,147 shares of the firm’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $32.02, for a total transaction of $1,445,606.94. Following the transaction, the insider directly owned 727,768 shares of the company’s stock, valued at approximately $23,303,131.36. This trade represents a 5.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Balaji Gandhi sold 4,183 shares of Phreesia stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total transaction of $97,380.24. Following the completion of the transaction, the chief financial officer owned 99,125 shares in the company, valued at approximately $2,307,630. This represents a 4.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 92,244 shares of company stock valued at $2,680,720. Insiders own 5.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on PHR shares. Canaccord Genuity Group lifted their price target on Phreesia from $34.00 to $38.00 and gave the stock a “buy” rating in a report on Friday, September 5th. Needham & Company LLC boosted their target price on Phreesia from $29.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, September 5th. Mizuho assumed coverage on Phreesia in a report on Wednesday, August 27th. They issued an “outperform” rating and a $36.00 price target for the company. Stephens reiterated an “overweight” rating and issued a $32.00 price target on shares of Phreesia in a research note on Wednesday, September 3rd. Finally, Raymond James Financial set a $33.00 price objective on shares of Phreesia and gave the stock an “outperform” rating in a report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $33.85.

Phreesia Stock Up 2.9%

Shares of NYSE PHR opened at $22.67 on Tuesday. The stock has a market cap of $1.36 billion, a PE ratio of -53.97 and a beta of 0.74. The company has a quick ratio of 2.12, a current ratio of 2.12 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $32.76. The business has a 50-day moving average price of $23.98 and a 200 day moving average price of $25.89.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Thursday, September 4th. The company reported $0.01 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.08. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The company had revenue of $117.26 million during the quarter, compared to analysts’ expectations of $116.39 million. During the same quarter in the previous year, the business earned ($0.03) earnings per share. The firm’s revenue for the quarter was up 14.9% on a year-over-year basis. Phreesia has set its FY 2026 guidance at EPS. Equities research analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.